info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +1-315-636-4233    uk UK: +44-162-237-0614     in IN: +91-826-083-6500
smrlogonew
  • Home
  • About
    • Why SMR
    • Research Methodology
    • Media Coverage
    • Join Our Team
  • Reports
    • Aerospace and Defense
    • Agriculture
    • Automotive
    • Chemicals and Materials
    • Consumer Goods
    • Energy and Power
    • Equipment and Machinery
    • Food and Beverages
    • Healthcare
    • Information and Communication Technology
    • Semiconductor and Electronics
    • Manufacturing and Construction
  • Our Practices
    • Syndicated Research
    • Consulting Services
    • Custom Research
    • Full-time Engagement Model
  • Insights
    • Press Release
    • Blog
  • Contact
 
Home » Healthcare » Microneedle Drug Delivery Systems Market Global Report, 2030

Microneedle Drug Delivery Systems Market: By Type (Solid, Hollow, Dissolving, Coated, Others), By Material (Silicon, Metal, Polymer, Others), By Application (Dermatology, Drug Delivery, Pain Management, Cancer Therapy, Vaccine Delivery, Others), By Geography, Size, Global Report, Forecast, 2021-2030

Published On: Apr-2022   |   Base Year: 2021   |   No Of Pages: 135   |   Historical Data: 2017 - 2020   |   Formats: PDF   |   Report ID: 12144109

Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Product Type & Application

In 2021, the global microneedle drug delivery systems market size was valued at USD 5.71 billion. The microneedle drug delivery systems market is forecasted to grow up to USD 10.14 billion in 2030, with an estimated CAGR of 6.5%. The North American region dominated the market by accounting for over 40% of the total market share in the world. Microneedles are the devices that are used in the delivery of pre-treatment in pore formation to the skin. These microneedles penetrate the skin to create a passage for drug transportation through the human body.

 

Microneedle Drug Delivery Systems Market Infographic 2020-2030

 

Market Drivers - Rising Prevalence of Obesity, Research and Development Proficiencies, Growing Investment for Healthcare Facilities

  • The rise in the overweight and obese population globally is significant in increasing the microneedle drug delivery systems market's size. According to the WHO, 39% of the world's population was overweight, and 13% of the total population was obese in 2016. 

 

  • The growing investment in better healthcare facilities and improvement of healthcare infrastructure worldwide is a significant driver that can foster the market's growth. In addition, the mounting number of strategic collaborations and partnerships between the public and private players for funding and application of new technologies can help boost the growth of the Microneedle Drug Delivery market extensively.

 

  • Moreover, the products that are currently assisting the market's growth are microneedle patch, hydrogel microneedle, silicon microneedle, metal microneedles, polymer microneedles, ceramic microneedles, oligonucleotide delivery, coated microneedles, dissolving microneedles, and hollow microneedles. Microneedles are currently used for medical applications such as vaccine therapy, peptide delivery, hormone delivery, lidocaine delivery, pain therapy, ocular delivery, and cancer therapy. One current product is CIT-8 (collagen induction therapy). Microneedles can also be expanded into the cosmetics industry, with the C-8 (Cosmetic type) being a prime example.

 

microneedle drug delivery systems market by share 2020-2030

 

Restraints - High Cost Associated with R&D Proficiencies, Limited Infrastructural Facilities

  • The research and development costs of the microneedle drug delivery system are very high, thus threatening the development of newer and improved technologies and, therefore, it is hampering the market's overall growth.

 

  • The limited infrastructural facilities in the companies worldwide can hinder the development of better technologies, which can adversely impact the market growth in future.

 

Opportunities - Upsurge in the Private-public Funding for Targeted Research, Rising Product Innovations and Developments, and Newer Applications

  • Due to the collaboration of public and private sectors for targeted research in developing countries and the presence of highly improved technologies, a tremendous opportunity to improve the overall market's growth in the future can be created.

 

  • The rising costs in the research and development activities for medical instruments and devices, especially in the developed and developing countries, will create better market opportunities in the future. In addition, R&D focused on reducing obesity will also create more significant market opportunities.

 

  • Moreover, the implementation of newer and improved technologies can help the market to grow further in the future. Other than the currently marketed products of transdermal drug delivery system, the use of nanotechnology in drug delivery, microneedles for drug delivery via the gastrointestinal tract, microneedle transdermal drug delivery, transdermal microneedles for drug delivery applications, transdermal microneedles for drug delivery applications, nanoparticle drug delivery, Solid microneedle, Hydrogel microneedle, 3m Microneedle Drug Delivery, Microneedle array, MS-4, MicroHyala, microstructured transdermal systems and microneedle drug delivery systems can augment the growth of the market share further in the upcoming years. 

 

Market Analysis Of Different Segments Covered in the Report

Based on Type

  • Solid

  • Hollow

  • Dissolving

  • Coated

  • Others

 

Based on Material

  • Silicon

  • Metal

  • Polymer

  • Others

 

Based on Application

  • Dermatology

  • Drug Delivery

  • Pain Management

  • Cancer Therapy

  • Vaccine Delivery

  • Others

 

microneedle drug delivery systems market by application 2020-2030

 

Regional Coverage Analysis

North America

  • United States of America

  • Canada

 

Europe

  • United Kingdom

  • Germany

  • France

  • Italy

  • Spain

 

Asia-Pacific

  • China

  • Japan

  • India

  • Thailand

  • South Korea

 

Latin America

  • Brazil

  • Mexico

  • Argentina

  • Colombia

 

Middle East and Africa

  • Saudi Arabia

  • South Africa

  • United Arab Emirates

 

Segments Analysis & Insights

Based on Type, the hollow microneedle segment had the largest revenue share of more than 26% in 2020. The hollow microneedles can administer a larger drug dose to a patient, making them suitable for vaccine and hormonal therapy.

 

Based on Material, the metal microneedle segment accounted for the largest revenue share, with more than 27% in 2020. Metals are more preferred for microneedle manufacture as they are strong enough to avoid breaking.

 

Based on application, the vaccine delivery segment is anticipated to expand quickly at a CAGR of 6.3% from 2020 to 2030. Due to the increased awareness of vaccination by the population, scientists can develop new vaccine administration methods.

 

Based on the region, North America accounted for the most significant share of market revenue, with over 40% in 2020. Due to the governments in North America forming different projects and reducing R&D costs, the North American market for microneedles has skyrocketed.

microneedle drug delivery systems market by region 2020-2030

Global Microneedle Drug Delivery Systems Market Competitive Landscape Analysis

Competitors in this market are evaluated based on company financials, revenue generated, market potential, new market investment, investment in R&D, and global presence.

The key players in this market are:

  • AdminMed nanoBioSciences LLC

  • Becton, Dickinson and Company

  • Zosano Pharma Corporation

  • Raphas Co. Ltd.

  • Nanopass Technologies Ltd.

  • Corium International, Inc. (Gurnet Point Capital)

  • Valeritas, Inc. (Zealand Pharma)

  • Nitto Denko Corporation

  • Endoderma Ltd.

  • Innoture Medical Technology Limited

 

Microneedle Drug Delivery Systems Market Report Coverage

Report Attribute

Details

Forecast Period

2021 - 2030

The market size value in 2021

USD 5.71 billion

The revenue forecast in 2030

USD 10.08 billion

Growth rate

CAGR of approximately 6.5%

The base year for estimation

2021

Historical data

2017 – 2020

Unit

USD Billion, CAGR (2021 - 2030)

Segmentation

Based on Type, Based on Material, Based on Application, Based on Region

Based on Type

Solid, Hollow, Dissolving, Coated, Others

 

Based on Material

Silicon, Metal, Polymer, Others

Based on Application

Dermatology, Drug Delivery, Pain Management, Cancer Therapy, Vaccine Delivery, Others

By Region

North America, Europe, Latin America, Middle East and Africa

Country Scope

United States of America, Mexico, United Arab Emirates, United Kingdom, Germany, France, Canada, China, India, Japan, South Korea, Brazil, Argentina, Saudi Arabia, South Africa

Company Usability Profiles

AdminMed nanoBioSciences LLC, Becton, Dickinson and Company, Zosano Pharma Corporation, Raphas Co. Ltd., Nanopass Technologies Ltd., Corium International, Inc. (Gurnet Point Capital), Valeritas, Inc. (Zealand Pharma), Nitto Denko Corporation, Endoderma Ltd., Innoture Medical Technology Limited

 

Recent Developments

  • In 2022, Zosano Pharma announced a publication of clinical data which demonstrated comparable immunogenicity of a Trivalent Influenza Vaccine formulated on the company's transdermal microneedle system versus an intramuscular injection of the vaccine at a higher dose. In addition, the data revealed that the vaccine was administered through their microneedle system and produced antibody levels that met the EMEA's three guidelines for the efficacy requirements of the influenza vaccine and were efficiently handled by the testers.

  • In 2021, PharmaTher announced positive research results for its LSD microneedle patch. These results can provide support for the company to continue phase 2 clinical studies in 2022 with LSD for various indications.

 

Various Microneedle Drug Delivery Systems Devices that Key Market Leaders Developed:

Name of the Product

Function

Key Players

MicroHyala

Treatment of age spots, acne and anti-ageing cosmetic products

CosMED Pharmaceutical Co. Ltd.

Soluvia

Intradermal Vaccination

Sanofi Pasteur Europe

MF-8 type

Treatment of Scars

Dermaroller

MS-4

Treatment of Acne Scars

Dermaroller

LiteClear

Treatment of acne and skin blemishes

Nanomed Skincare

h-patch

Delivery of drugs in subcutaneous tissue

Valeritas

Microstructured Transdermal System

Delivery of biologics and other small molecules

3M

Frequently Asked Question About This Report

The global microneedle drug delivery systems market size was $5.71 billion in 2021 and is predicted to reach $10.08 billion by 2030, with a CAGR of 6.5%.

The main factors that contribute to the growth of the market are the rising prevalence of obesity, R&D proficiencies, and the global investment in healthcare facilities.

The global microneedle drug delivery systems market is expected to grow at a compound annual growth rate (CAGR) of 6.5% from 2021 to 2030 to reach USD $ 10.08 billion by 2030.

The metallic material has captured the most market share globally, with more than 27% in 2021.

North America has the highest revenue, with more than 40%.

.

1.   Introduction

       1.1. Study Objective

       1.2. Market Definition        

       1.3. Study Scope

              1.3.1. Markets Covered

              1.3.2. Geographic Scope

              1.3.3. Years Considered

              1.3.4. Stakeholders

2.   Research Methodology

       2.1. Data Procurement

       2.2. Paid Database

              2.2.1. Secondary Data

                     2.2.1.1. Key Secondary sources

              2.2.2. Primary Data

                     2.2.2.1 Primary sources

                     2.2.2.2. Key industry insights

                     2.2.2.3. Primary interviews with experts

                     2.2.2.4. Key primary respondent list

       2.3. Market Size Estimation

       2.4. Bottom-Up and Top-Down Approaches

              2.4.1.     Bottom-Up Approach

                     2.4.1.1.         Approach for arriving at Market size by bottom-up analysis

              2.4.2.     Top-Down Approach

                     2.4.2.1.         Approach for Capturing Market Size by Top-Down Analysis

       2.5. Market Breakdown and Data Triangulation

       2.6. Research Methodology

       2.7. Risk Assessment

3.  Executive Summary

       3.1   Market: Post-Covid-19

              3.1.1      Actual Scenario

              3.1.2      Pessimistic Scenario

              3.1.3      Optimistic Scenario

              3.1.4      Market Summary

4. Industry Outlook

       4.1  Market Snapshot

       4.2 Global Microneedle Drug Delivery Systems Market

              4.2.1       Market, 2021 – 2030 (USD Million)

       4.3  Regional Analysis

              4.3.1       Market, by region, 2021 - 2030 (USD Million)

       4.4  By Type Analysis

              4.4.1       Market, By Type, 2021 - 2030 (USD Million)

       4.5  By Material Analysis

              4.5.1       Market, By Material, 2021 - 2030 (USD Million)

       4.6  By Application Analysis

              4.6.1       Market, By Application, 2021 - 2030 (USD Million)

5. Market Dynamics

       5.1. Introduction

       5.2. Market Dynamics

              5.2.1.     Drivers

              5.2.2.     Restraints

              5.2.3.     Opportunities

              5.2.4.     Challenges

       5.3. Impact of Covid-19

       5.4. Value Chain Analysis

       5.5. Ecosystem

       5.6. Patent Analysis

       5.7. Trade Analysis

       5.8. Tariff Analysis

       5.9. Case Study Analysis

5.10.      Porter’s Five Forces Analysis

              5.10.1    Threat of New Entrants

              5.10.2    Threat of Substitutes

              5.10.3    Bargaining Power of Buyers

              5.10.4    Bargaining Power of Suppliers

              5.10.5    Degree of Competition

       5.11.              By Application Analysis

              5.11.1.   Trends in Application (2014-2021)

              5.11.2.   Trends in Application (2021-2030)

       5.12.              Pricing Analysis

              5.12.1.   Average Price Trend Analysis (By region, By Countries)

6. Competitive & Vendor Landscape

       6.1. Company Market Share Analysis

       6.2. Manufacturers  Manufacturing Sites, Area Served, Product Type

       6.3.  Market Competitive Situation and Trends

       6.4. Manufacturers Mergers & Acquisitions, Expansion Plans

7.  Market: By Type Segment Analysis

       7.1. Introduction

       7.2. Sales Volume & Revenue Analysis (2021-2030)

       7.3. Solid

              7.3.1. Solid Market, 2021 - 2030 (USD Million)

       7.4. Hollow

              7.4.1. Hollow Market, 2021 - 2030 (USD Million)

       7.5. Dissolving

              7.5.1. Dissolving Market, 2021 - 2030 (USD Million)

       7.6. Coated

              7.6.1. Coated Market, 2021 - 2030 (USD Million)

       7.7. Others

              7.7.1. Others Market, 2021 - 2030 (USD Million)

8.  Market: By Material Segment Analysis

       8.1. Introduction

       8.2. Sales Volume & Revenue Analysis (2021-2030)

       8.3. Silicon

              8.3.1.     Silicon Market, 2021 - 2030 (USD Million)

       8.4. Metal

              8.4.1.     Metal Market, 2021 - 2030 (USD Million)

       8.4. Polymer

              8.4.1.     Polymer Market, 2021 - 2030 (USD Million)

       8.5. Other

              8.5.1.     Other Market, 2021 - 2030 (USD Million)

 

9.  Market: By Application Segment Analysis

       9.1. Introduction

       9.2. Sales Volume & Revenue Analysis (2021-2030)

       9.3. Dermatology

              9.3.1.     Dermatology Market, 2021 - 2030 (USD Million)

       9.4. Drug Delivery

              9.4.1.     Drug Delivery Market, 2021 - 2030 (USD Million)

       9.5. Pain Management

              9.5.1.     Pain Management Market, 2021 - 2030 (USD Million)

       9.6. Cancer Therapy

              9.6.1.     Cancer Therapy Market, 2021 - 2030 (USD Million)

       9.7. Vaccine Delivery

              9.7.1.     Vaccine Delivery Market, 2021 - 2030 (USD Million)

       9.8. Other

              9.8.1.     Other  Market, 2021 - 2030 (USD Million)

 

10.  Market: Regional Outlook

       10.1 North America

              10.1.1.   North America   Market, by By Type, 2021 - 2030 (USD Million)

              10.1.2.   North America   Market, by By Material, 2021 - 2030 (USD Million)

              10.1.3.   North America   Market, by Application, 2021 - 2030 (USD Million)

              10.1.4.   North America   Market, by Country, 2021 - 2030 (USD Million)

       10.1.4.1. U.S.

                     10.1.4.1.1.   U.S.  Market, by By Type, 2021 - 2030 (USD Million)

                     10.1.4.1.2.   U.S.  Market, by By Material, 2021 - 2030 (USD Million)

                     10.1.4.1.3.   U.S.  Market, by Application, 2021 - 2030 (USD Million)

     10.1.4.2.  Canada

                     10.1.4.2.1.   Canada  Market, by By Type, 2021 - 2030 (USD Million)

                     10.1.4.2.2.   Canada  Market, by By Material, 2021 - 2030 (USD Million)

                     10.1.4.2.3.   Canada  Market, by Application, 2021 - 2030 (USD Million)

10.2. Europe

              10.2.1.   Europe  Market, by By Type, 2021 - 2030 (USD Million)

              10.2.2.   Europe  Market, by By Material, 2021 - 2030 (USD Million)

              10.2.3.   Europe  Market, by Application, 2021 - 2030 (USD Million)

              10.2.4.   Europe  Market, by country, 2021 - 2030 (USD Million)

    10.2.4.1    U.K.

                     10.2.4.1.1.   U.K.  Market, by By Type, 2021 - 2030 (USD Million)

                     10.2.4.1.2.   U.K.  Market, by By Material, 2021 - 2030 (USD Million)

                     10.2.4.1.3.   U.K.  Market, by Application, 2021 - 2030 (USD Million)

   10.2.4.2.           Germany

                     10.2.4.2.1.   Germany  Market, by By Type, 2021 - 2030 (USD Million)

                     10.2.4.2.2.   Germany  Market, by By Material, 2021 - 2030 (USD Million)

                     10.2.4.2.3.   Germany  Market, by Application, 2021 - 2030 (USD Million)

   10.2.4.3.           France

                     10.2.4.3.1.   France  Market, by By Type, 2021 - 2030 (USD Million)

                     10.2.4.3.2.   France  Market, by By Material, 2021 - 2030 (USD Million)

                     10.2.4.3.3.   France  Market, by Application, 2021 - 2030 (USD Million)

    10.2.4.4.          Rest of Europe

                     10.2.4.4.1.   Rest of Europe  Market, by By Type, 2021 - 2030 (USD Million)

                     10.2.4.4.2.   Rest of Europe  Market, by By Material, 2021 - 2030 (USD Million)

                     10.2.4.4.3.   Rest of Europe  Market, by Application, 2021 - 2030 (USD Million)

       10.3.              Asia Pacific

              10.3.1.   Asia Pacific  Market, by By Type, 2021 - 2030 (USD Million)

              10.3.2.   Asia Pacific  Market, by By Material, 2021 - 2030 (USD Million)

              10.3.3.   Asia Pacific  Market, by Application, 2021 - 2030 (USD Million)

              10.3.4.   Asia Pacific  Market, by country, 2021 - 2030 (USD Million)

   10.3.4.1.           China

                     10.3.4.1.1.   China  Market, by By Type, 2021 - 2030 (USD Million)

                     10.3.4.1.2.   China  Market, by By Material, 2021 - 2030 (USD Million)

                     10.3.4.1.3.   China  Market, by Application, 2021 - 2030 (USD Million)

   10.3.4.2.           India

                     10.3.4.2.1.   India  Market, by By Type, 2021 - 2030 (USD Million)

                     10.3.4.2.2.   India  Market, by By Material, 2021 - 2030 (USD Million)

                     10.3.4.2.3.   India   Market, by Application, 2021 - 2030 (USD Million)

   10.3.4.3.           Japan

                     10.3.4.3.1.   Japan  Market, by By Type, 2021 - 2030 (USD Million)

                     10.3.4.3.2.   Japan  Market, by By Material, 2021 - 2030 (USD Million)

                     10.3.4.3.3.   Japan  Market, by Application, 2021 - 2030 (USD Million)

   10.3.4.4.           South Korea

                     10.3.4.4.1.   South Korea  Market, by By Type, 2021 - 2030 (USD Million)

                     10.3.4.4.2.   South Korea  Market, by By Material, 2021 - 2030 (USD Million)

                     10.3.4.4.3.   South Korea  Market, by Application, 2021 - 2030 (USD Million)

10.3.4.5.              Rest of ASIA PACIFIC

                     10.3.4.5.1.   Rest of ASIA PACIFIC  Market, by By Type, 2021 - 2030 (USD Million)

                     10.3.4.5.2.   Rest of ASIA PACIFIC  Market, by By Material, 2021 - 2030 (USD Million)

                     10.3.4.5.3.   Rest of ASIA PACIFIC  Market, by Application, 2021 - 2030 (USD Million)

       10.4.              Latin America

              10.4.1.   Latin America  Market, by By Type, 2021 - 2030 (USD Million)

              10.4.2.   Latin America  Market, by By Material, 2021 - 2030 (USD Million)

              10.4.3.   Latin America  Market, by Application, 2021 - 2030 (USD Million)

              10.4.4.   Latin America  Market, by country, 2021 - 2030 (USD Million)

10.4.4.1.              Brazil

                     10.4.4.1.1.   Brazil  Market, by By Type, 2021 - 2030 (USD Million)

                     10.4.4.1.2.   Brazil  Market, by By Material, 2021 - 2030 (USD Million)

                     10.4.4.1.3.   Brazil  Market, by Application, 2021 - 2030 (USD Million)

10.4.4.2.              Mexico

                     10.4.4.2.1.   Mexico  Market, by By Type, 2021 - 2030 (USD Million)

                     10.4.4.2.2.   Mexico  Market, by By Material, 2021 - 2030 (USD Million)

                     10.4.4.2.3.   Mexico  Market, by Application, 2021 - 2030 (USD Million)

                     10.4.4.3.       Rest of the Latin America

                     10.4.4.3.1.   Rest of the Latin America  Market, by By Type, 2021 - 2030 (USD Million)

                     10.4.4.3.2.   Rest of the Latin America  Market, by By Material, 2021 - 2030 (USD Million)

                     10.4.4.3.3.   Rest of the Latin America  Market, by Application, 2021 - 2030 (USD Million)

       10.5.              MEA

              10.5.1.   MEA  Market, by By Type, 2021 - 2030 (USD Million)

              10.5.2.   MEA  Market, by By Material, 2021 - 2030 (USD Million)

              10.5.3.   MEA  Market, by Application, 2021 - 2030 (USD Million)

              10.5.4.   MEA  Market, by Region, 2021 - 2030 (USD Million)

 

11. Competitive Landscape

       11.1 AdminMed nanoBioSciences LLC

              11.1.1.   Company overview

              11.1.2.   Financial performance

              11.1.3.   Product Portfolio Analysis

              11.1.4.   Business Strategy & Recent Development

 

       11.2. BECTON, DICKINSON AND COMPANY

              11.2.1.   Company overview

              11.2.2.   Financial performance

              11.2.3.   Product Portfolio Analysis

              11.2.4.   Business Strategy & Recent Development

 

       11.3. Zosano Pharma Corporation

              11.3.1.   Company overview

              11.3.2.   Financial performance

              11.3.3.   Product Portfolio Analysis

              11.3.4.   Business Strategy & Recent Development

       11.4. RAPHAS CO. LTD

              11.4.1.   Company overview

              11.4.2.   Financial performance

              11.4.3.   Product Portfolio Analysis

              11.4.4.   Business Strategy & Recent Development

       11.5. NANOPASS TECHNOLOGIES LTD

              11.5.1.   Company overview

              11.5.2.   Financial performance

              11.5.3.   Product Portfolio Analysis

              11.5.4.   Business Strategy & Recent Development

 

       11.6. Corium International, Inc. (Gurnet Point Capital)

              11.6.1.   Company overview

              11.6.2.   Financial performance

              11.6.3.   Product Portfolio Analysis

              11.6.4.   Business Strategy & Recent Development

       11.7. Valeritas, Inc. (Zealand Pharma)

              11.7.1.   Company overview

              11.7.2.   Financial performance

              11.7.3.   Product Portfolio Analysis

              11.7.4.   Business Strategy & Recent Development

       11.8. Nitto Denko Corporation

              11.8.1.   Company overview

              11.8.2.   Financial performance

              11.8.3.   Product Portfolio Analysis

              11.8.4.   Business Strategy & Recent Development

       11.9. Endoderma Ltd.

              11.9.1.   Company overview

              11.9.2.   Financial performance

              11.9.3.   Product Portfolio Analysis

              11.9.4.   Business Strategy & Recent Development

       11.10. Innoture Medical Technology Limited

              11.10.1. Company overview

              11.10.2. Financial performance

              11.10.3. Product Portfolio Analysis

              11.10.4. Business Strategy & Recent Development

 

List of Tables (55 Tables)

TABLE 1.   MARKET, By Type, 2021-2030 (USD Million)

TABLE 2.   MARKET FOR Solid, BY REGION, 2021-2030 (USD Million)

TABLE 3.   MARKET FOR Hollow, BY REGION, 2021-2030 (USD Million)

TABLE 4.   MARKET FOR Dissolving, BY REGION, 2021-2030 (USD Million)

TABLE 5.   MARKET FOR Coated, BY REGION, 2021-2030 (USD Million)

TABLE 6.   MARKET FOR Others, BY REGION, 2021-2030 (USD Million)

TABLE 7.  MARKET, By Material, 2021-2030 (USD Million)

TABLE 8.  MARKET FOR Silicon, BY REGION, 2021-2030 (USD Million)

TABLE 9.  MARKET FOR Metal, BY REGION, 2021-2030 (USD Million)

TABLE 10.  MARKET FOR Polymer, BY REGION, 2021-2030 (USD Million)

TABLE 11.  MARKET FOR Others, BY REGION, 2021-2030 (USD Million)

TABLE 12.  MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 13.  MARKET FOR Dermatology, BY REGION, 2021-2030 (USD Million)

TABLE 14.  MARKET FOR Drug Delivery, BY REGION, 2021-2030 (USD Million)

TABLE 15.  MARKET FOR Pain Management, BY REGION, 2021-2030 (USD Million)

TABLE 16.  MARKET FOR Cancer Therapy, BY REGION, 2021-2030 (USD Million)

TABLE 17.  MARKET FOR Vaccine Delivery, BY REGION, 2021-2030 (USD Million)

TABLE 18.  MARKET FOR Other, BY REGION, 2021-2030 (USD Million)

 

TABLE 19.  MARKET, BY REGION, 2021-2030 (USD Million)

TABLE 20. NORTH AMERICA  MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 21. NORTH AMERICA  MARKET, By Type, 2021-2030 (USD Million)

TABLE 22. NORTH AMERICA  MARKET, By Material, 2021-2030 (USD Million)

TABLE 23. NORTH AMERICA  MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 24. EUROPE  MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 25. EUROPE  MARKET, By Type, 2021-2030 (USD Million)

TABLE 26. EUROPE  MARKET, By Material, 2021-2030 (USD Million)

TABLE 27. EUROPE  MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 28. ASIA-PACIFIC  MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 29. ASIA-PACIFIC  MARKET, By Type, 2021-2030 (USD Million)

TABLE 30. ASIA-PACIFIC  MARKET, By Material, 2021-2030 (USD Million)

TABLE 31. ASIA-PACIFIC  MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 32. LAMEA  MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 33. LAMEA  MARKET, By Type, 2021-2030 (USD Million)

TABLE 34. LAMEA  MARKET, By Material, 2021-2030 (USD Million)

TABLE 35. LAMEA  MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 36. AdminMed nanoBioSciences LLC: COMPANY SNAPSHOT

TABLE 37. AdminMed nanoBioSciences LLC: OPERATING SEGMENTS

TABLE 38. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT

TABLE 39. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS

TABLE 40. Zosano Pharma Corporation: COMPANY SNAPSHOT

TABLE 41. Zosano Pharma Corporation: OPERATING SEGMENTS

TABLE 42. RAPHAS CO. LTD: COMPANY SNAPSHOT

TABLE 43. RAPHAS CO. LTD: OPERATING SEGMENTS

TABLE 44. NANOPASS TECHNOLOGIES LTD : COMPANY SNAPSHOT

TABLE 45. NANOPASS TECHNOLOGIES LTD : OPERATING SEGMENTS

TABLE 46. Corium International, Inc. (Gurnet Point Capital): COMPANY SNAPSHOT

TABLE 47. Corium International, Inc. (Gurnet Point Capital): OPERATING SEGMENTS

TABLE 48. Valeritas, Inc. (Zealand Pharma): COMPANY SNAPSHOT

TABLE 49. Valeritas, Inc. (Zealand Pharma): OPERATING SEGMENTS

TABLE 50. Nitto Denko Corporation: COMPANY SNAPSHOT

TABLE 51. Nitto Denko Corporation: OPERATING SEGMENTS

TABLE 52. ENDODERMA LTD.: COMPANY SNAPSHOT

TABLE 53. ENDODERMA LTD.: OPERATING SEGMENTS

TABLE 54. Innoture Medical Technology Limited: COMPANY SNAPSHOT

TABLE 55. Innoture Medical Technology Limited: OPERATING SEGMENTS

 

List of Figures (22 Figures)

Figure 1  Market: Research Methodology Steps

Figure 2 Research Design

Figure 3 Breakdown of Primaries:  Market

Figure 4 Research Methodology: Hypothesis Building

Figure 5  Market: Product-Based Estimation

Figure 6 Top 10 Companies with Highest No. Of Patent in Last 9 Years

Figure 7 No. Of Patents Granted Per Year, 2019–2021

Figure 8 Import Data for , By Country, 2016–2021 (USD Thousand)

Figure 9 Export Data for , By Country, 2016–2021 (USD Thousand)

Figure 10 Data Triangulation Methodology

Figure 11  Market, By Material, 2019 vs. 2025 (USD Million)

Figure 12  Market Share, By Application, 2019 vs. 2025 (USD Million)

Figure 13  Market Share, By Type, 2019 vs. 2025 (USD Million)

Figure 14 Geographical Snapshot of the  Market

Figure 15 Hollow to Witness Higher CAGR in  Market for Type Segment during Forecast Period.

Figure 16 Vaccine Delivery to Witness Higher CAGR in  Market for Application Segment during Forecast Period.

Figure 17 Metal to Witness Higher CAGR in  Market for Material Segment during Forecast Period.

Figure 18 North America region Accounted for the Largest Share of the  Market, By Regional Basis, in 2019

Figure 19  Market: Drivers, Restraints, Opportunities, and Challenges

Figure 20 North America:  Market Snapshot

Figure 21 Asia Pacific:  Market Snapshot

Figure 22 Vendor Dive: Evaluation Overview

 

 

Choose License Type


$4485
$6449
$8339
Buy Now
"Click to avail the latest sample copy of the report"
Request Sample
"Probe before placing the order"
Pre-Order Enquiry
"Let's optimize your ROI by furnishing the best price"
Request Discount
"Want to curate the report according to your business needs:"
Ask for Customization
Related Reports
Buy Now
Request Sample

Trust Online

  • paypal.png
  • wiretransfers

Follow Us

  • facebook
  • twitter
  • instagram
  • linkedin

Contact Us

  • US: +1-315-636-4233
  • UK: +44-162-237-0614
  • IN: +91-826-083-6500
  • info@strategicmarketresearch.com
  • Strategic Market Research
    26, Broadway Suite 934, New York , 10004

Quick Link

  • Why SMR
  • Research Methodology
  • Media Coverage
  • Join Our Team
  • Press Release
  • Blog

Customer Support

  • FAQs
  • Contact
  • Terms of Use
  • Privacy Policy
  • Disclaimer Policy
  • Return Policy
Copyright © 2022 Strategic Market Research All rights reserved.